News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
56 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (335)
2 (311)
3 (237)
4 (70)
6 (2)
7 (48)
8 (54)
9 (56)
10 (84)
11 (40)
13 (1)
14 (80)
15 (90)
16 (78)
17 (59)
18 (31)
20 (1)
21 (91)
22 (78)
23 (75)
24 (68)
25 (25)
26 (1)
28 (4)
29 (222)
30 (262)
31 (261)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
20
21
22
23
24
25
26
28
29
30
31
BioMidwest
Centene Corporation Announces Offering Of Senior Notes
Offering to sell $1.7 billion aggregate principal amount of senior notes due 2026, subject to market and other conditions.
May 9, 2018
·
3 min read
Business
Seres Therapeutics Reports First Quarter Financial Results and Provides Operational Updates
Preclinical data provide mechanistic insights related to the potency of microbiome therapeutics to augment immuno-oncology treatments; initiation of clinical study in metastatic melanoma planned for later this year
May 9, 2018
·
11 min read
Business
Mylan Reports First Quarter 2018 Results and Reaffirms 2018 Guidance
Total revenues of $2.68 billion, down 1% compared to the prior year period.
May 9, 2018
·
61 min read
Biotech Bay
BioClin Therapeutics, Inc., Completes $50 Million Series B Financing with Addition of New Investors
Series B financing to broaden its clinical development activities.
May 9, 2018
·
3 min read
Job Trends
incentaHEALTH Launches New Visual Approach to Diabetes Prevention
Program offers an intrinsically pleasurable approach to disease prevention and curbing the obesity crisis through visual weigh ins and cash incentives for weight loss
May 9, 2018
·
3 min read
BioForest
Bardy Diagnostics™ Announces Validation of AI-Enabled Automatic Screening Technology for Atrial Fibrillation
Bardy Diagnostics, Inc. is the provider of the world’s only P-wave centric™ ambulatory cardiac patch monitor and arrhythmia detection device
May 9, 2018
·
3 min read
FDA
SeptiCyte™ LAB Differentiates Sepsis from SIRS in the ICU
Design and results of clinical trials that led to FDA clearance of SeptiCyte™ LAB published in the American Journal of Respiratory and Clinical Care Medicine
May 9, 2018
·
4 min read
Business
MEI Pharma Reports Third Quarter Fiscal Year 2018 Results
Data readouts in three programs expected in the second calendar quarter of 2018
May 9, 2018
·
13 min read
Biotech Bay
Adventus Ventures announces initial financing for several of its medical device portfolio companies
Adventus Ventures, LLC, a medical device company incubator and early stage medical device VC, announced today that it has completed initial financing for several of its portfolio companies
May 9, 2018
·
1 min read
BioCapital
Five Things to Know About the 6.2 Billion-Dollar Biosimilar Business
Kalorama Information estimates that the global market for biosimilar products has grown to be worth almost $6.2 billion by the end of the year, according to its new report, Biosimilars: Global Market, Trends and Competitor Analysis.
May 9, 2018
·
4 min read
Previous
5 of 6
Next